title: Primary lamivudine resistance in acute/early human immunodeficiency virus infection.
authors.affiliation: University of British Columbia, Vancouver, Canada. brian_conway@viridae.com
authors.forename: B
authors.initials: B
authors.lastname: Conway
authors.forename: V
authors.initials: V
authors.lastname: Montessori
authors.forename: D
authors.initials: D
authors.lastname: Rouleau
authors.forename: J S
authors.initials: JS
authors.lastname: Montaner
authors.forename: M V
authors.initials: MV
authors.lastname: O'Shaughnessy
authors.forename: S
authors.initials: S
authors.lastname: Fransen
authors.forename: A
authors.initials: A
authors.lastname: Shillington
authors.forename: O
authors.initials: O
authors.lastname: Weislow
authors.forename: D L
authors.initials: DL
authors.lastname: Mayers
mesh_terms: D000208:Acute Disease; D000328:Adult; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial / Q000235:genetics; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine